4//SEC Filing
Partridge Andrew John 4
Accession 0001209191-21-046809
CIK 0001595893other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 5:53 PM ET
Size
5.1 KB
Accession
0001209191-21-046809
Insider Transaction Report
Form 4
Partridge Andrew John
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-07-14$74.90/sh−1,869$139,988→ 21,767 total
Footnotes (1)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with vesting of a restricted stock unit award granted to Reporting Person on July 13, 2020.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001758838
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 5:53 PM ET
- Size
- 5.1 KB